Neurotoxin Modeling of Brain Disorders — Life-long Outcomes in Behavioral Teratology

1. Neuroteratology and Animal Modeling of Brain Disorders
Trevor Archer, Richard M. Kostrzewa

2. Perinatal Lesioning and Lifelong Effects of the Noradrenergic Neurotoxin 6-Hydroxydopa
Richard M. Kostrzewa

3. Selective Lifelong Destruction of Brain Monoaminergic Nerves Through Perinatal DSP-4 Treatment
Przemysław Nowak

4. Noradrenergic–Dopaminergic Interactions Due to DSP-4–MPTP Neurotoxin Treatments: Iron Connection
Trevor Archer

5. Perinatal Domoic Acid as a Neuroteratogen
Tracy A. Doucette, R. Andrew Tasker

6. Perinatal 192 IgG-Saporin as Neuroteratogen
Laura Petrosini, Paola De Bartolo, Debora Cutuli, Francesca Gelfo

7. NGF in Early Embryogenesis, Differentiation, and Pathology in the Nervous and Immune Systems
Luisa Bracci-Laudiero, Maria Egle De Stefano

8. Disrupted Circadian Rhythm as a Common Player in Developmental Models of Neuropsychiatric Disorders
Eva M. Marco, Elena Velarde, Ricardo Llorente, Giovanni Laviola

9. Neurobehavioral Effects from Developmental Methamphetamine Exposure
Sarah A. Jablonski, Michael T. Williams, Charles V. Vorhees

10. Early-Life Toxic Insults and Onset of Sporadic Neurodegenerative Diseases—an Overview of Experimental Studies
Anna Maria Tartaglione, Aldina Venerosi, Gemma Calamandrei

11. The Use of Perinatal 6-Hydroxydopamine to Produce a Rodent Model of Lesch–Nyhan Disease
Darin J. Knapp, George R. Breese

12. Perinatal 6-Hydroxydopamine Modeling of ADHD
John P. Kostrzewa, Rose Anna Kostrzewa, Richard M. Kostrzewa, Ryszard Brus, Przemysław Nowak

13. Attention-Deficit/Hyperactivity Disorder: Focus upon Aberrant N-Methyl-d-Aspartate Receptors Systems
Trevor Archer, Danilo Garcia

14. Perinatal 6-Hydroxydopamine to Produce a Lifelong Model of Severe Parkinson’s Disease
John P. Kostrzewa, Rose Anna Kostrzewa, Richard M. Kostrzewa, Ryszard Brus, Przemysław Nowak

15. Exercise and Nutritional Benefits in PD: Rodent Models and Clinical Settings
Trevor Archer, Richard M. Kostrzewa

16. Lifelong Rodent Model of Tardive Dyskinesia—Persistence After Antipsychotic Drug Withdrawal
Richard M. Kostrzewa, Ryszard Brus

17. Perinatal Influences of Valproate on Brain and Behaviour: An Animal Model for Autism
Peter Ranger, Bart A. Ellenbroek

18. Applications of the Neonatal Quinpirole Model to Psychosis and Convergence upon the Dopamine D2 Receptor
Russell W. Brown, Daniel J. Peterson

19. Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review
B. Grayson, S. A. Barnes, A. Markou, C. Piercy, G. Podda, J. C. Neill

20. Pathological Implications of Oxidative Stress in Patients and Animal Models with Schizophrenia: The Role of Epidermal Growth Factor Receptor Signaling
Tadasato Nagano, Makoto Mizuno, Keisuke Morita, Hiroyuki Nawa

Nyckelord: Biomedicine, Neurosciences, Psychopharmacology, Neurobiology